Improving HIV Prevention Services in Syringe Programs
SAIA-PrEP: a systems analysis and improvement approach to optimize PrEP implementation in syringe service programs
['FUNDING_R01'] · UNIVERSITY OF CALIFORNIA, SAN DIEGO · NIH-11110333
This project helps syringe service programs offer better HIV prevention medicine (PrEP) to people who inject drugs.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN DIEGO (nih funded) |
| Locations | 1 site (LA JOLLA, UNITED STATES) |
| Trial ID | NIH-11110333 on ClinicalTrials.gov |
What this research studies
HIV infections are unfortunately rising among people who inject drugs, even though a highly effective prevention medicine called PrEP is available. Many syringe service programs already provide some HIV services, like education and testing, making them ideal places to offer PrEP. This project provides extra support to these programs to help them improve how they deliver PrEP services. We are testing a special approach called SAIA (Systems Analysis and Improvement Approach) to see if it helps programs better connect people with PrEP.
Who could benefit from this research
Good fit: This project aims to benefit people who inject drugs and are at risk for HIV by improving their access to PrEP through syringe service programs.
Not a fit: Patients not at risk for HIV or not engaged with syringe service programs may not directly benefit from this specific intervention.
Why it matters
Potential benefit: If successful, this work could significantly increase access to life-saving HIV prevention medicine for people who inject drugs, helping to stop the spread of HIV.
How similar studies have performed: While PrEP is proven effective, this specific organizational intervention (SAIA) to optimize its delivery in syringe service programs is a novel approach being tested in a randomized controlled trial.
Where this research is happening
LA JOLLA, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN DIEGO — LA JOLLA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BAZZI, ANGELA ROBERTSON — UNIVERSITY OF CALIFORNIA, SAN DIEGO
- Study coordinator: BAZZI, ANGELA ROBERTSON
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus